Pebblebrook Q3 10-Q: $77.3M Impairment Drives $(0.56) Loss Despite Record RevPAR
PEB has more than doubled off its 52-week low of $9.99.
Summary
Pebblebrook's Q3 revenue of $402.7 million and Hotel EBITDA of $115.2 million beat last year, but a $77.3 million impairment on three hotels drove a $(0.56) per-share loss; Adjusted FFO still rose to $71.6 million.
Key Events · Earnings and Guidance · PEB
-
Q3 Revenue and Hotel EBITDA Grow
Total revenues rose to $402.7 million from $398.7 million and Hotel EBITDA to $115.2 million from $105.4 million, with same-property RevPAR up to $256.66 from $236.96.
-
$77.3M Impairment Drives GAAP Loss
A $77.3 million impairment on three hotels produced a net loss attributable to common shareholders of $(63.1) million, or $(0.56) per share, versus $(0.37) a year earlier.
-
Adjusted FFO Rises to $71.6M
Adjusted FFO available to common share and unit holders increased to $71.6 million from $60.2 million, showing the impairment is non-cash and operating cash flow improved.
-
Disposal Program Continues
Chamberlain West Hollywood sold for $43.5 million in May 2026 and The Hotel Zags closed at $10.0 million on October 8, 2026; nine-month impairments totaled $86.1 million across four hotels.
Analysis · PEB · Real Estate & Construction
The quarter's operating engine is running well — same-property RevPAR rose to $256.66 from $236.96 and Hotel EBITDA climbed to $115.2 million from $105.4 million — but a $77.3 million impairment on three hotels pushed the GAAP result to a $(63.1) million loss, or $(0.56) per share. That gap between cash earnings and reported loss is the whole story: Adjusted FFO rose to $71.6 million from $60.2 million, so the impairment is a non-cash write-down of properties management now expects to sell at lower values, not a cash drain. The nine-month impairment of $86.1 million (versus $46.5 million a year ago) confirms a deliberate disposal program — Chamberlain West Hollywood sold for $43.5 million in May and The Hotel Zags closed at $10.0 million on October 8. Balance-sheet risk is low: $939.1 million of liquidity, no revolver borrowings, and all debt covenants met, with the $350 million convertible notes due December 2026 earmarked for repayment from cash and the Term Loan 2031 delayed draw.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PEB was trading at $21.72 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $2.5B. The 52-week trading range was $9.99 to $21.90. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.